Akihiro Furuta

President at AskAt, Inc.

64 year

Health Technology

Consumer Services

Profile

Akihiro Furuta is currently the President & Representative Director at AskAt, Inc. Previously, he worked as the Director, Senior Head-Personnel & Operations at RaQualia Pharma, Inc. from 2012 to 2014.
He obtained his undergraduate degree from Oberlin College and Nagoya University.

Akihiro Furuta active positions

Companies	Position	Start
AskAt, Inc. AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015.	President	-

All active positions of Akihiro Furuta

Former positions of Akihiro Furuta

Companies	Position	End
RAQUALIA PHARMA INC.	Chief Tech/Sci/R&D Officer	08/06/2012

See the detail of Akihiro Furuta's experience

Training of Akihiro Furuta

Nagoya University	Undergraduate Degree
Oberlin College	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Akihiro Furuta's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
RAQUALIA PHARMA INC.	Health Technology

Private companies	1
AskAt, Inc. AskAt, Inc. Pharmaceuticals: MajorHealth Technology AskAt, Inc. was founded in 2013 and is committed to optimizing the drug discovery process to deliver groundbreaking medications for pain, cancer, and dementia to patients worldwide. The company is based in Nagoya, Japan. The Japanese company's portfolio includes a focus on pain, cancer, and dementia, and their corporate philosophy and vision are centered around delivering innovative solutions to improve patient outcomes. AskAt was acquired by AskAat, Inc. /Yoshida/ from RaQualia Pharma, Inc. on May 14, 2015.	Health Technology